| OMNICELL INC. DL-,001 |
| USA |
| Gesundheit |
| US68213N1090 / 632313 |
| OC9 (Frankfurt) / OMCL (NASDAQ) |
| FRA:OC9, ETR:OC9, OC9:GR, NASDAQ:OMCL |
| - |
| https://www.omnicell.com/ |
|
Omnicell Inc. operates as a provider of medication..
>Volltext.. |
| 1204.12 Mio. EUR |
| 1164.16 Mio. EUR |
| 986.69 Mio. EUR |
| 89.87 Mio. EUR |
| 19.82 Mio. EUR |
| 0.43 EUR |
| 329.96 Mio. EUR |
| 370.38 Mio. EUR |
| 126.82 Mio. EUR |
| 0.73 |
| -3.26% |
| - |
| - |
| - |
| - |
| - |
| OMNICELL |
| 30.10.25 |
|